Teva
Teva sells generic, innovative and biosimilar medicines across many countries, placing it in the metabolic pool's international expansion layer, where results hinge on conducting business globally amid tariffs, trade-policy shifts and regional instability.
Revised after a check against the company's own annual filing.
Latest disclosed
10-Q filed 2026-07-29 · period ending 2026-06-30
Pieces naming this company
None yet.
No price is shown: the Index is a map of what each company sells and where it sits, not a quote board.